These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19017951)

  • 1. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal.
    Chaigne-Delalande B; Guidicelli G; Couzi L; Merville P; Mahfouf W; Bouchet S; Molimard M; Pinson B; Moreau JF; Legembre P
    J Immunol; 2008 Dec; 181(11):7630-8. PubMed ID: 19017951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An atypical necrotic signal induced by immunosuppressive and anti-viral agents.
    Chaigne-Delalande B; Guidicelli G; Couzi L; Legembre P
    Autophagy; 2009 Apr; 5(3):425-7. PubMed ID: 19221465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells.
    Guidicelli G; Chaigne-Delalande B; Dilhuydy MS; Pinson B; Mahfouf W; Pasquet JM; Mahon FX; Pourquier P; Moreau JF; Legembre P
    PLoS One; 2009; 4(5):e5493. PubMed ID: 19430526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
    Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
    J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
    Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
    Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
    Goldsmith D; Carrey EA; Edbury S; Smolenski RT; Jagodzinski P; Simmonds HA
    Clin Sci (Lond); 2004 Jul; 107(1):63-8. PubMed ID: 14723604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of mycophenolate mofetil.
    Allison AC
    Lupus; 2005; 14 Suppl 1():s2-8. PubMed ID: 15803924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil and its mechanisms of action.
    Allison AC; Eugui EM
    Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
    Dayton JS; Turka LA; Thompson CB; Mitchell BS
    Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.
    Ohata K; Espinoza JL; Lu X; Kondo Y; Nakao S
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):205-13. PubMed ID: 20736080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanosine-5'-triphosphate increases in red blood cells of heart transplant recipients treated with mycophenolate mofetil.
    Griesmacher A; Weigel G; Seebacher G; Müller MM
    Adv Exp Med Biol; 2000; 486():139-43. PubMed ID: 11783471
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes.
    Jagodzinski P; Lizakowski S; Smolenski RT; Slominska EM; Goldsmith D; Simmonds HA; Rutkowski B
    Clin Sci (Lond); 2004 Jul; 107(1):69-74. PubMed ID: 14723603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.
    Maksimovic-Ivanic D; Trajkovic V; Miljkovic DJ; Mostarica Stojkovic M; Stosic-Grujicic S
    Clin Exp Immunol; 2002 Aug; 129(2):214-23. PubMed ID: 12165076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
    Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
    Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil: An update.
    Villarroel MC; Hidalgo M; Jimeno A
    Drugs Today (Barc); 2009 Jul; 45(7):521-32. PubMed ID: 19834629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.
    Takebe N; Cheng X; Wu S; Bauer K; Goloubeva OG; Fenton RG; Heyman M; Rapoport AP; Badros A; Shaughnessy J; Ross D; Meisenberg B; Tricot G
    Clin Cancer Res; 2004 Dec; 10(24):8301-8. PubMed ID: 15623606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil.
    Devyatko E; Zuckermann A; Bohdjalian A; Roedler S; Dunkler D; Grimm M; Weigel G
    Transplantation; 2006 Jul; 82(1):113-8. PubMed ID: 16861950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.